Profund Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,710
| Closed | -$112K | – | 1185 |
|
|
2024
Q1 | $112K | Sell |
22,710
-15,882
| -41% | -$78.1K | ﹤0.01% | 1121 |
|
|
2023
Q4 | $339K | Buy |
38,592
+3,631
| +10% | +$31.9K | 0.01% | 719 |
|
|
2023
Q3 | $401K | Buy |
34,961
+16,355
| +88% | +$188K | 0.02% | 532 |
|
|
2023
Q2 | $471K | Buy |
18,606
+1,585
| +9% | +$40.1K | 0.03% | 533 |
|
|
2023
Q1 | $548K | Buy |
+17,021
| New | +$548K | 0.03% | 479 |
|
|
2021
Q3 | – | Sell |
-6,944
| Closed | -$205K | – | 1459 |
|
|
2021
Q2 | $205K | Buy |
+6,944
| New | +$205K | 0.01% | 1345 |
|
|
2018
Q4 | – | Sell |
-11,144
| Closed | -$277K | – | 1458 |
|
|
2018
Q3 | $277K | Buy |
+11,144
| New | +$277K | 0.01% | 1250 |
|